<div class="chapter"><div class="chapter"><h2 class="title">CHAPTER 22. <a name="page404"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">404</span></span>Diseases of the Lacrimal Apparatus</h2><div class="section" id="ch22lev1sec1"><h1 class="title">SYMPTOMS AND SIGNS</h1>
<p class="noindent">The diseases of the lacrimal apparatus are divided into two groups: Abnormalities of the lacrimal glands; defects in the drainage system.</p>
<ol style="list-style-type: decimal">
<li><p class=""><span class="italic">Abnormalities of the lacrimal glands:</span></p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Excessive tear secretion:</span> Reflex stimulation of the main lacrimal gland.</p></li>
<li><p class=""><span class="italic">Deficient tear formation:</span> Atrophy of the lacrimal gland and conjunctival scarring leading to occlusion of the main and accessory lacrimal glands.</p></li>
<li><p class=""><span class="italic">Characteristic swelling with S-shaped upper lid:</span> Neoplasms or inflammatory diseases of the lacrimal gland.</p></li>
</ul></li>
<li><p class=""><span class="italic">Defects in the lacrimal drainage system:</span></p>
<ul style="list-style-type: square">
<li><p class="">Cause watering from the eye.</p></li>
<li><p class="">Obstructed lacrimal sac may be chronically or acutely inflamed.
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Acute inflammation</span> causes cellulitis of the sac and surrounding structures, and lacrimal abscess formation.</p></li>
<li><p class=""><span class="italic">Chronic inflammation</span> causes painless swelling in the sac region, with regurgitation of pus through the puncta, when pressure is applied to the sac area.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Excessive tear formation</span> or poor drainage is a nuisance, since the vision is blurred by tears and discomfort caused by overflow of tears onto the cheek.</p></li>
<li><p class=""><span class="italic">Deficient tear formation</span> may cause blurring of the vision, irritation, and is associated with ocular surface diseases (OSD), i.e., dryness of the cornea and conjunctiva.</p></li>
</ul></li>
</ol>
</div><div class="section" id="ch22lev1sec2"><h1 class="title">DISEASES OF THE LACRIMAL GLAND</h1>
<div class="section" id="ch22lev2sec1"><h2 class="title">Acute Dacryoadenitis (<a href="#ch22fig1" class="ulink-inter">Fig. 22.1</a>)</h2>
<ul style="list-style-type: bullet">
<li><p class="">It usually accompanies a systemic disease like mumps, influenza or glandular fever.</p></li>
<li><p class="">It is characterized by acute local pain, swelling and tenderness, and drooping of the outer part of upper lid with a characteristic S-shaped curve.</p></li>
<li><p class=""><span class="italic">Treatment:</span> The infection is usually self-limiting. Antibiotics with local hot compress may be required in some cases.</p></li>
</ul>
<div class="figure" id="ch22fig1" data-label="Fig. 22.1"><div class="title"><span class="item-label">Fig. 22.1</span> Acute dacryoadenitis right side—S-shaped right upper eyelid.</div><img alt="Fig. 22.1" src="/MediumImage/404-1.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page405"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">405</span></span></p>
</div>
<div class="section" id="ch22lev2sec2"><h2 class="title">Chronic Dacryoadenitis</h2>
<p class="noindent">A proliferative inflammation of the lacrimal gland may occur as a part of generalized granulomatous disorders (e.g., syphilis, tuberculosis or sarcoidosis). It presents as a painless, firm, mobile swelling of the lacrimal gland.</p>
<div class="section" id="ch22lev3sec1"><h3 class="title">Mikulicz Syndrome</h3>
<p class="noindent">It is characterized by a symmetrical swelling of the lacrimal and salivary glands, and may occur as a part of sarcoidosis, Hodgkin's disease or one of the lukemias.</p>
</div>
<div class="section" id="ch22lev3sec2"><h3 class="title">Dacryops (<a href="#ch22fig2" class="ulink-inter">Fig. 22.2</a>)</h3>
<p class="noindent">It is a cystic swelling in the upper fornix due to retention of secretion owing to blockage of one of the lacrimal ducts.</p>
<p class="noindent"><span class="italic">Treatment</span> is surgical excision or marsupialization of the retention cyst via the conjunctival route.</p>
</div>
</div>
<div class="section" id="ch22lev2sec3"><h2 class="title">Lacrimal Gland Tumors</h2>
<ul style="list-style-type: bullet">
<li><p class="">They are relatively rare, and show a marked resemblance to the parotid gland tumors.</p></li>
<li><p class="">They present in middle-aged, progress slowly, until they become palpable as hard, nodular and slightly mobile lumps.</p></li>
<li><p class=""><span class="italic">Proptosis</span> occurs in downwards and medially, along with limitation of movements and diplopia.</p></li>
<li><p class=""><span class="italic">Benign mixed tumors</span> form the majority and have an excellent prognosis if they are excised completely with their capsule.</p></li>
<li><p class=""><span class="italic">Carcinomas</span> have a more rapid onset, often with pain and lymph node involvement. Local hyperostosis of the orbital bone is often evident on X-ray.</p></li>
</ul>
<div class="figure" id="ch22fig2" data-label="Fig. 22.2"><div class="title"><span class="item-label">Fig. 22.2</span> Dacryops of the lacrimal gland.</div><img alt="Fig. 22.2" src="/MediumImage/405-1.jpg"><div class="additional-markup"></div></div>
<div class="section" id="ch22lev3sec3"><h3 class="title">Treatment</h3>
<p class="noindent">A biopsy may be needed to confirm the diagnosis. If malignant, a radical surgical removal, or a full exenteration of the orbit is often advisable.</p>
</div>
</div>
</div><div class="section" id="ch22lev1sec3"><h1 class="title">DRY EYE SYNDROME</h1>
<p class="noindent">A dry eye syndrome is said to exist when the quantity or the quality of the precorneal tear-film is insufficient to ensure the well-being of ocular epithelial surface.</p>
<div class="section" id="ch22lev2sec4"><h2 class="title">Dry Eye</h2>
<p class="noindent">Dry eye is a multifactorial disease of the tears and ocular surface that results in discomfort, visual disturbance and tears film instability with potential damage to the ocular surface. It is accompanied by increased tear osmolarity and inflammation of the ocular surface [definition given by dry eye workshop (DEWS) in 2007].</p>
<div class="sidebar">
<h2 class="title">DEWS II report redefines dry eye in 2017</h2>
<p class="">“Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles.”</p>
</div>
<p class="indent">In most of the situations, it results from a localized immune-mediated inflammatory response affecting both the lacrimal gland and the ocular surface.</p>
<p class="noindent"><span class="italic">Other commonly used terms:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Tear-film dysfunction:</span> It is a disturbance in the tear-film function owing to change in lipid, water or mucin component of the tears.<a name="page406"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">406</span></span></p></li>
<li><p class=""><span class="italic">Ocular surface disorders</span></p></li>
<li><p class=""><span class="italic">Keratoconjunctivitis sicca (KCS):</span> It is a deficiency of aqueous component of the tear-film.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Primary KCS:</span> Involvement of the lacrimal gland alone.</p></li>
<li><p class=""><span class="italic">Secondary KCS:</span> When there are additional features of connective tissue disorders.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Sjögren syndrome (primary):</span> It is an autoimmune disease, characterized by a dry eye (xerophthalmia) and a dry mouth (xerostomia), due to involvement of both lacrimal and salivary glands.
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Secondary Sjögren syndrome:</span> When they are associated with a connective tissue disorders, such as seropositive rheumatoid arthritis, systemic lupus erythematosus (SLE), systemic sclerosis, polymyositis, etc.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Xerosis:</span> It is a dryness of the conjunctiva, and presents as wrinkling, thickening, pigmentation and dryness of the conjunctiva.</p></li>
<li><p class=""><span class="italic">Xerophthalmia:</span> When the same xerotic process spreads over the cornea, mainly caused by vitamin A deficiency.</p></li>
<li><p class=""><span class="italic">Keratomalacia:</span> It is the softening and aseptic necrosis of the cornea, usually due to vitamin A deficiency along with malnutrition.</p></li>
</ul>
</div>
<div class="section" id="ch22lev2sec5"><h2 class="title">Symptoms</h2>
<p class="noindent">The symptoms are typically worse during night-time, or awakening from sleep (as sleep decreases the tear production) and they include:</p>
<ul style="list-style-type: bullet">
<li><p class="">Foreign body (sandy/gritty) sensation</p></li>
<li><p class="">Transient blurring of vision</p></li>
<li><p class="">Excessive stringy mucus</p></li>
<li><p class="">Burning sensation</p></li>
<li><p class="">Photophobia</p></li>
<li><p class="">Intolerance to drafts and winds</p></li>
<li><p class="">Constant awareness about the eye itself.</p></li>
</ul>
</div>
<div class="section" id="ch22lev2sec6"><h2 class="title">Causes</h2>
<div class="informaltable"><div class="table-scroll"><table class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Categories</span></p></th>
<th class="left"><p class=""><span class="italic">Causes</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><bold>Aqueous tear deficiency</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Keratoconjunctivitis sicca</p></li>
<li><p class="">Sjögren syndrome</p></li>
<li><p class="">Riley-Day syndrome</p></li>
<li><p class="">Trauma to lacrimal gland</p></li>
<li><p class="">Surgical removal of lacrimal gland</p></li>
<li><p class="">Infiltrations by—sarcoidosis, lymphoma, amyloidosis, etc.</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Drug-induced, like antihistaminics, antimuscarinics, thiabendazole, etc.</p></li>
<li><p class="">Neuroparalytic hyposecretion</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Mucin-deficiency</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Goblet cell dysfunctions, as in hypovitaminosis A</p></li>
<li><p class="">Goblet cell destruction, in alkali burn, trachoma, pemphigoid, Stevens-Johnson syndrome</p></li>
<li><p class="">Drug-induced: Beta-blockers (practolol), echothiophate iodide</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Lipid abnormalities</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Anhidrotic ectodermal dysplasia (congenital absence of meibomian glands)</p></li>
<li><p class="">Various types of blepharitis including meibomianitis</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Lid surfacing abnormalities</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Lagophthalmos</p></li>
<li><p class="">Exposure keratitis</p></li>
<li><p class="">Entropion, ectropion</p></li>
<li><p class="">Lid-notching</p></li>
<li><p class="">Coloboma of the lid</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Epitheliopathy</bold></p></td>
<td class="left"><p class="">
<ul style="list-style-type: bullet">
<li><p class="">Recurrent erosions</p></li>
<li><p class="">Limbal lesions</p></li>
<li><p class="">Hard contact lens</p></li>
<li><p class="">Topical anesthesia</p></li>
</ul></p></td>
</tr>
</tbody>
</table></div></div>
</div>
<div class="section" id="ch22lev2sec7"><h2 class="title">Signs</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Precorneal tear-film:</span> Increased amounts of mucus strands and debris in the upper and lower tear-menisci (meniscus floaters).<a name="page407"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">407</span></span></p>
<p class=""><div class="figure" id="ch22fig3" data-label="Figs. 22.3A and B"><div class="title"><span class="item-label">Figs. 22.3A and B</span> <bold>A.</bold> Normal tear-meniscus height after fluorescein staining. Normal lower tear-meniscus height = 0.2–0.5 mm; <bold>B.</bold> Diminished lower tear-meniscus height &lt;0.2 mm after fluorescein staining in keratoconjunctivitis sicca.</div><img alt="Figs. 22.3A and B" src="/MediumImage/407-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Marginal tear-strip (tear-meniscus):</span> Marginal tear-strip is reduced and it contains mucus and debris (normal lower tear meniscus height is about 0.2–0.5 mm) <bold>(<a href="#ch22fig3" class="ulink-inter">Figs. 22.3A and B</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Conjunctiva:</span>
<ul style="list-style-type: square">
<li><p class="">Hyperemia of the conjunctiva.</p></li>
<li><p class="">Appearance of folds on the temporal side, especially on abduction.</p></li>
<li><p class="">Papillary conjunctivitis (a nonspecific reaction).</p>
<p class=""><div class="figure" id="ch22fig4" data-label="Fig. 22.4"><div class="title"><span class="item-label">Fig. 22.4</span> Punctated keratopathies and corneal filaments after fluorescein stain in keratoconjunctivitis sicca.</div><img alt="Fig. 22.4" src="/MediumImage/407-2.jpg"><div class="additional-markup"></div></div></p></li>
</ul></p></li>
<li><p class=""><span class="italic">Cornea:</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Superficial punctuate keratitis (<a href="#ch22fig4" class="ulink-inter">Fig. 22.4</a>)</span> involving the inferior cornea, which is stained by fluorescein and Rose-Bengal.</p></li>
<li><p class=""><span class="italic">Filaments (<a href="#ch22fig5" class="ulink-inter">Fig. 22.5</a>)</span> are short tails that hang from the corneal surface.</p>
<p class="">They are composed of central mucus core encased by epithelial cells and stained with the Rose-Bengal and fluorescein.</p></li>
<li><p class="">Mucus plaques are attached loosely to the corneal surface and are also stained by Rose-Bengal dye.</p></li>
<li><p class=""><span class="italic">Dellen and Vascularization (<a href="#ch22fig6" class="ulink-inter">Fig. 22.6</a>),</span> in severe dry eye; but not associated with limbal lesions.</p></li>
<li><p class=""><span class="italic">Thinning</span> occurs in severe dry eye and sometimes with perforation.</p></li>
</ul></p></li>
</ul>
<div class="figure" id="ch22fig5" data-label="Fig. 22.5"><div class="title"><span class="item-label">Fig. 22.5</span> Pathogenesis of filamentary keratopathy.</div><img alt="Fig. 22.5" src="/MediumImage/407-3.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page408"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">408</span></span></p>
<div class="figure" id="ch22fig6" data-label="Fig. 22.6"><div class="title"><span class="item-label">Fig. 22.6</span> Dellen and superficial vascularization in severe dry eye.</div><img alt="Fig. 22.6" src="/MediumImage/408-1.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch22lev2sec8"><h2 class="title">Special Clinical Tests</h2>
<div class="section" id="ch22lev3sec4"><h3 class="title">Vital Dye Staining</h3>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Fluorescein (2%) staining (<a href="#ch22fig7" class="ulink-inter">Fig. 22.7</a>):</span> It stains precorneal tear-film and intercellular tissue. It does not stain the mucus and devitalized epithelial cells.</p></li>
<li><p class=""><span class="italic">Rose-Bengal (1%) staining (<a href="#ch22fig8" class="ulink-inter">Figs. 22.8A and B</a>):</span> It has an affinity for devitalized epithelial cells, mucus and filaments. It is very useful to detect mild cases of dry eye by staining the interpalpebral conjunctiva in the form of two triangles with their bases towards the limbus. Topical anesthesia should not be used prior to Rose-Bengal staining, as it may induce false-positive result.</p></li>
<li><p class=""><span class="italic">Lissamine green staining (<a href="#ch22fig9" class="ulink-inter">Fig. 22.9</a>):</span> It is also used to stain the surface similar to Rose-Bengal stain.</p></li>
<li><p class=""><span class="italic">Alcian blue staining:</span> It is used to stain the mucus more selectively (not commonly used).</p></li>
</ul>
<div class="figure" id="ch22fig7" data-label="Fig. 22.7"><div class="title"><span class="item-label">Fig. 22.7</span> Fluorescein stain—filamentary keratopathy and corneal staining.</div><img alt="Fig. 22.7" src="/MediumImage/408-2.jpg"><div class="additional-markup"></div></div>
</div>
<div class="section" id="ch22lev3sec5"><h3 class="title">Tear-Film Break-up Time</h3>
<p class="noindent">It is a simple test to assess the stability of the precorneal tear-film.</p>
<ul style="list-style-type: bullet">
<li><p class="">A drop of fluorescein is instilled, and the patient is asked to blink 2–3 times to distribute the dye.</p></li>
<li><p class="">The patient is then asked not to blink while the cornea is studied by the cobalt blue filter with the slit lamp.</p></li>
</ul>
<div class="figure" id="ch22fig8" data-label="Figs. 22.8A and B"><div class="title"><span class="item-label">Figs. 22.8A and B</span> Keratoconjunctivitis sicca typical Rose-Bengal staining. <bold>A.</bold> Conjunctiva; <bold>B.</bold> Cornea.</div><img alt="Figs. 22.8A and B" src="/MediumImage/408-3.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page409"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">409</span></span></p>
<div class="figure" id="ch22fig9" data-label="Fig. 22.9"><div class="title"><span class="item-label">Fig. 22.9</span> Lissamine green staining in dry eye.</div><img alt="Fig. 22.9" src="/MediumImage/409-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch22fig10" data-label="Fig. 22.10"><div class="title"><span class="item-label">Fig. 22.10</span> Schirmer's test.</div><img alt="Fig. 22.10" src="/MediumImage/409-2.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">The tear-film break-up time (TBUT) is the time in seconds between the last blink and the appearance of dry (black) spots on the cornea.</p></li>
<li><p class="">A normal TBUT is more than 10 seconds (11–35 seconds), and a TBUT value less than 10 seconds is abnormal.</p></li>
</ul>
</div>
<div class="section" id="ch22lev3sec6"><h3 class="title">Schirmer's Test (<a href="#ch22fig10" class="ulink-inter">Fig. 22.10</a>)</h3>
<ul style="list-style-type: bullet">
<li><p class="">A 5 mm wide and 35 mm long special filter paper (Whatman no. 41) is placed in the lower fornix at the junction of the middle and outer-third of the eyelid after folding it at 5 mm. After 5 minutes, the amount of wetting from the fold is measured. Patient may blink or close the eyes as necessary during the test.</p></li>
<li><p class="">This is <span class="italic">Schirmer's test I</span> and done without anesthesia. It measures the total secretion (i.e., basic plus reflex tears).
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Values of Schirmer's test I</span></p>
<p class=""><span class="italic">Normal value:</span> 11–25 mm</p>
<p class=""><span class="italic">Borderline:</span> 5–10 mm</p>
<p class=""><span class="italic">Impaired secretion:</span> Less than 5 mm</p></li>
<li><p class="">Schirmer's test I may be done after topical anesthesia, which measures only the <span class="italic">basic secretion</span>.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Schirmer's test II</span> measures the <span class="italic">reflex secretion</span> only. The procedure is same except, instillation of topical anesthesia, in the eye and irritation of ipsilateral nasal mucosa with a camel hairbrush or cotton swab during the test.</p>
<p class="">The reading is taken after 2 minutes, and a measurement of less than 15 mm indicates failure of reflex secretion. This test is seldom used.</p></li>
</ul>
</div>
</div>
<div class="section" id="ch22lev2sec9"><h2 class="title">Laboratory Tests</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Tear lysozyme assay:</span> It is estimated by placing a tear-wetted filter strip in an agar plate containing the bacteria <span class="italic">Micrococcus lysodeikticus,</span> and zone of lysis is measured after incubation at +37°C for 24 hours. In KCS there is a reduction in tear lysozyme.</p></li>
<li><p class=""><span class="italic">Tear osmolarity:</span> Its normal range is 290–311 mOsm/L, and it increases in KCS. Tear osmolarity value above 316 mOsmol/L is diagnostic of dry eye disease.</p></li>
<li><p class=""><span class="italic">Fluorescein dilution test:</span> One drop of fluorescein is instilled in the eye and the dilution over a period of time is measured photometrically to calculate the tear volume.</p></li>
<li><p class=""><span class="italic">Conjunctival impression cytology (CIC):</span> The impression is taken with a cellulose acetate filter paper strip from the bulbar conjunctiva, and then stained by Papanicolaou's technique. The specimen is then analyzed for normal and abnormal cells, goblet cells and distribution of different cells. It is important in mucin deficiency states as well as in KCS.<a name="page410"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">410</span></span></p></li>
<li><p class=""><span class="italic">Hematological tests:</span> They are important to detect etiological factors responsible for dry eye, as in collagen vascular disorders [rheumatoid factor, antinuclear factor (ANF), erythrocyte sedimentation rate (ESR), etc.].</p></li>
</ul>
</div>
<div class="section" id="ch22lev2sec10"><h2 class="title">Levels of Severity of Dry Eye (DEWS Classification)*</h2>
<div class="informaltable"><div class="table-scroll"><table>



<thead>
<tr>
<th class="left"><p class=""><span class="italic">Levels</span></p></th>
<th class="left"><p class=""><span class="italic">Previous term</span></p></th>
<th class="left"><p class=""><span class="italic">Clinical features</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><bold>Level 1</bold></p></td>
<td class="left"><p class="">Mild dry eye</p></td>
<td class="left"><p class="">Mild conjunctival signs; normal Schirmer; slightly lower TBUT; no other problems</p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Level 2</bold></p></td>
<td class="left"><p class="">Moderate dry eye</p></td>
<td class="left"><p class="">Mild corneal signs, abnormal TBUT, abnormal Schirmer's value</p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Level 3</bold></p></td>
<td class="left"><p class="">Severe dry eye</p></td>
<td class="left"><p class="">Marked conjunctival and corneal sign; abnormal TBUT and Schirmer; symptomatic</p></td>
</tr>
<tr>
<td class="left"><p class=""><bold>Level 4</bold></p></td>
<td class="left"><p class="">Extremely severe dry eye</p></td>
<td class="left"><p class="">More visual symptoms; severe corneal erosions; constant features</p></td>
</tr>
<tr>
<td colspan="3" class="left"><p class="small">* International Dry Eye Workshop (DEWS) 2007.</p>
<p class="small"><span class="italic">Abbreviation:</span> TBUT—Tear-film break-uptime</p></td>
</tr>
</tbody>
</table></div></div>
</div>
<div class="section" id="ch22lev2sec11"><h2 class="title">Treatment</h2>
<p class="noindent">There is no permanent cure for the dry eye, but there are some options available to relieve symptoms.</p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Preservation of the existing tears:</span>
<ul style="list-style-type: square">
<li><p class="">Reduction of the room temperature.</p></li>
<li><p class=""><span class="italic">Humidifiers:</span> Examples are swimmer's goggles, moist chamber goggles, etc.</p></li>
<li><p class="">Plenty of intakes of drinking water.</p></li>
<li><p class="">Lid taping and tarsorrhaphy to prevent exposure keratitis.</p></li>
<li><p class=""><span class="italic">Punctal occlusion:</span> It is to preserve the natural or artificial tears in contact with the ocular surface for a longer time.
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Temporary:</span> By solid gelatin rods, collagen plugs, cyanoacrylate glue, ‘2-0’ catgut pieces, or heat cautery.</p></li>
<li><p class=""><span class="italic">Permanent:</span> For severe cases of KCS when the Schirmer's value is less than 2 mm. This is done by silicone plugs, thermodynamic acrylic plugs, electrocautery or by small patch graft over the puncta.</p></li>
</ul></p></li>
</ul></p></li>
<li><p class=""><span class="italic">Supplementation of tears:</span> Essentially six types of tear substitutes are currently available in the market. The compositions of tear substitutes are cellulose (methyl cellulose, hydroxypropyl methyl cellulose, hypermellose), polyvinyl alcohol, povidone, hydroxy propyl guar (HP Guar), Propylene glycol (PEG), and sodium hyaluronate. They are used either alone or in combination.</p>
<p class=""><span class="italic">A preservative-free eye drop is more preferable for long-term use,</span> as some of the preservatives may cause dryness, e.g., benzalkonium chloride (BAK). Nobel preservatives, like Purite and perborate containing tears substitute are more important when the frequency of instillation is more than six times per day for a prolonged period.</p>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Drops:</span> Frequency of instillation may vary with the severity of dry eye 4 times/daily to half-hourly interval.</p></li>
<li><p class=""><span class="italic">Ointments:</span> Petroleum mineral oil or jelly is used at bedtime as an ointment.</p></li>
<li><p class=""><span class="italic">Gel-tears:</span> The gel is a clear synthetic polymer of acrylic acid which dissolves very slowly. It persists in the conjunctival sac for several hours after instillation. Temporary blurring of vision may be a problem.</p></li>
</ul></li>
<li><p class=""><span class="italic">Stimulation of tears production: Bromhexine and eledosin</span> are sometimes used for stimulation of the lacrimal gland to produce more tears. <span class="italic">Oral pilocarpine or pilocarpine-like drug (Cevelamine)</span> may also be used to stimulate tears production. But, they have systemic muscarinic like toxicity.</p></li>
<li><p class=""><span class="italic">Mucolytic agent:</span> Acetylcysteine (5% or 10%) drops 4 times daily, when there is excessive production of mucus strands. It has an unpleasant sulfurous odor.<a name="page411"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">411</span></span></p></li>
<li><p class=""><span class="italic">Bandage soft contact lenses:</span> High hydrated bandage contact lenses occupy a unique place in the treatment of dry eye. They are most valuable in filamentary keratopathy, recurrent epithelial erosions and exposure keratitis.</p></li>
<li><p class=""><span class="italic">Systemic and topical corticosteroids:</span> They are useful for underlying systemic diseases, in patients with secondary KCS.</p>
<p class=""><span class="italic">Topicals of steroids</span> (like loteprednol) may be used 4–6 times daily for a short period of time (pulse therapy) to reduce ocular surface inflammation in selective cases.</p></li>
<li><p class=""><span class="italic">Cyclosporine:</span> Topical cyclosporine (0.05% or 0.09%) is now currently recommended in patient with moderate to severe dry eye due to primary or secondary KCS.</p>
<p class="">Cyclosporine, an immune modulator inhibits activation of T lymphocytes and prevents T cells in releasing cytokines. It is given twice daily for at least 6 months.</p></li>
<li><p class=""><span class="italic">Major surgical procedures</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Parotid duct and smaller labial salivary glands transplantation:</span> They are rarely performed nowadays.</p></li>
<li><p class=""><span class="italic">Tarsorrhaphy or botulinum toxin:</span> It is to reduce the exposed ocular surface area.</p></li>
<li><p class=""><span class="italic">Limbal stem cell transplantation</span> (autograft or allograft).</p></li>
<li><p class=""><span class="italic">Corneal transplantation and keratoprosthesis:</span> They are more heroic measures used to treat severe form of dry eye. But, they are often unsuccessful in preserving vision in severe dry eye.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Treatment of associated problems:</span> These include treatment of blepharitis, meibomianitis, conjunctivitis, corneal ulcer, entropion, symblepharon, etc.</p></li>
<li><p class=""><span class="italic">Change in working environment:</span> This is also important especially who works in air-conditioned environment and spend a long time with the computer or smart phone.</p></li>
<li><p class=""><span class="italic">Psychotherapy:</span> This includes explaining to the patient about the disease and its future course. Because of its chronic nature, most patients go through periods of despondency and depression. Ophthalmologists must actively encourage these patients to continue to pursue their normal activities.</p></li>
</ul>
<div class="sidebar">
<h2 class="title">Management outline of dry eye diseases (DEWS II recommendation)</h2>
<p class=""><span class="italic">Level 1</span></p>
<p class="">(i) Counseling, (ii) dietary modification, (iii) tears substitute (any type) 4 times/day, (iv) environmental management, (v) systemic medication review, (vi) control ocular allergy and (vii) address contact lens problems.</p>
<p class=""><span class="italic">Level 2</span></p>
<p class="">(i) Steps from level one, (ii) tears supplement– preservative-free (6–8 times), (iii) oral tetracycline analogs, (iv) topical anti-inflammatory agents,</p>
<p class="">(v) topical cyclosporine (0.05%): twice daily, (vi) reversible lacrimal occlusion and (vii) lid hygiene/nutritional support (omega-3 fatty acid).</p>
<p class=""><span class="italic">Level 3</span></p>
<p class="">(i) Steps from level one and two, (ii) tears substitute (preservative-free) 1 hourly, (iii) autologous serum eye drop (20–50%), (iv) bandage contact lens and (v) permanent punctal occlusion.</p>
<p class=""><span class="italic">Level 4</span></p>
<p class="">(i) Steps from level one, two and three, (ii) tears supplement (P/F)—1/2 hourly to 1 hourly, (iii) oral anti-inflammatory medications, (iii) oral cyclosporine, (iv) acetyl cysteine 20% eye drop, (v) tarsorrhaphy or botulinum toxin and (vi) limbal stem cell transplantation (auto/allograft).</p>
</div>
</div>
</div><div class="section" id="ch22lev1sec4"><h1 class="title">WATERING FROM THE EYE</h1>
<p class="noindent">Watering is associated with blurring of vision and continuous discomfort caused by tears running down the cheek.</p>
<p class="indent">In all instances, it is necessary to find out, whether there is excessive production of the tears (lacrimation), or its defective drainage (epiphora).</p>
<p class="noindent"><span class="italic">Lacrimation:</span> Excessive secretion of tears, due to reflex stimulation of lacrimal gland.</p>
<p class="noindent"><span class="italic">Causes</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Psychic stimulation, as in weeping or laughing.<a name="page412"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">412</span></span></p></li>
<li><p class="">Irritation of the cornea or conjunctiva, by dust, smoke, fumes, chemicals, foreign body, inflammation, etc.</p></li>
<li><p class="">In yawning, coughing, sneezing or vomiting.</p></li>
<li><p class="">Exposure to bright lights.</p></li>
</ul>
<p class="noindent"><span class="italic">Epiphora:</span> Defective drainage of tears due to fault in the lacrimal passage.</p>
<p class="noindent"><span class="italic">Causes:</span> Mechanical obstruction in the drainage system, due to:</p>
<ul style="list-style-type: bullet">
<li><p class="">Congenital absence or occlusion of the puncta</p></li>
<li><p class="">Canaliculitis, canalicular obstruction</p></li>
<li><p class="">Congenital dacryocystitis</p></li>
<li><p class="">Chronic or acute dacryocystitis</p></li>
<li><p class="">Neoplasms of the lacrimal sac</p></li>
<li><p class="">Nasal pathology, like polyps, tumors in the inferior meatus of the nose.</p></li>
<li><p class=""><span class="italic">Lacrimal pump failure due to:</span>
<ul style="list-style-type: square">
<li><p class="">Lower lid laxity.</p></li>
<li><p class="">Weakness of the orbicularis oculi, as in Bell's palsy.</p></li>
<li><p class="">Ectropion due to other causes.</p></li>
</ul></p></li>
</ul>
<div class="section" id="ch22lev2sec12"><h2 class="title">Special Investigations</h2>
<p class="noindent">Special investigations of watering from the eye have been described in <bold><a href="#ch22tbl1" class="ulink-inter">Table 22.1</a></bold>.</p>
</div>
<div class="section" id="ch22lev2sec13"><h2 class="title">Evaluation of Watering from the Eye</h2>
<div class="section" id="ch22lev3sec7"><h3 class="title">History</h3>
<ul style="list-style-type: bullet">
<li><p class="">Watering due to epiphora is usually unilateral and is not associated with irritation. On the other hand, watering due to lacrimation is usually bilateral and associated with irritation, itching or photophobia.</p></li>
<li><p class="">Past history of Bell's palsy is important, and it suggests lacrimal pump failure rather than a mechanical obstruction.</p></li>
<li><p class="">History of medications like topical idoxuridine (IDU), latonoprost, mitomycin-C and systemic 5-FU (fluorouracil) may cause <span class="italic">punctal stenosis</span>.</p></li>
</ul>
</div>
<div class="section" id="ch22lev3sec8"><h3 class="title">Examinations</h3>
<p class="noindent"><span class="italic">Inspection:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Eyelids:</span> For trichiasis, ectropion, lower lid laxity, blocked puncta, etc.</p></li>
<li><p class=""><span class="italic">Medial canthal (sac) area:</span> For swelling (e.g., mucocele, acute dacryocystitis), fistula, etc.</p></li>
<li><p class=""><span class="italic">Orbicularis functions:</span> By forcible closure of the eyelids.</p></li>
</ul>
<p class="noindent"><span class="italic">Palpation:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Pressure over the sac area:</span> There is regurgitation of mucus (mucocele) or pus (pyocele) or mucopus through the lower as well as upper punctum. <bold>(ROPLAS:</bold> +<bold>ve</bold> <span class="italic">means</span> <bold>R</bold>egugitation <bold>O</bold>n <bold>P</bold>ressure over <bold>LA</bold>crimal <bold>S</bold>ac is positive)
<ul style="list-style-type: square">
<li><p class="">Sometimes, this mucopus evacuates inside the nasopharynx (as the patient complains) on giving pressure over the sac region.</p></li>
<li><p class="">In some cases, there may not be any swelling or ‘ROPLAS: negative’ (as the patient herself/himself had evacuated out the pus or mucopus by giving pressure over sac region before clinical examination).</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Tenderness</span> on palpation—in acute dacryocystitis.</p></li>
</ul>
<p class="noindent"><span class="italic">Slit-lamp examination:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Puncta:</span> Look for stenosis, foreign body, malposition, etc.</p></li>
<li><p class=""><span class="italic">Pressure over the canaliculi</span> with glass rod and look for pus coming out through the puncta.</p></li>
<li><p class=""><span class="italic">Marginal tear-film strip</span> for a high lower marginal tear-strip.</p></li>
<li><p class="">Look for any corneal or conjunctival pathology.</p></li>
</ul>
<p class="noindent"><span class="italic">Nasal examination:</span></p>
<ul style="list-style-type: bullet">
<li><p class="">To detect deviated nasal septum (DNS), polyps or tumor.</p></li>
<li><p class="">To detect hypertrophy of the inferior turbinate.<a name="page413"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">413</span></span></p></li>
</ul>
<div class="table" id="ch22tbl1"><div class="title"><span class="item-label">TABLE 22.1</span> Special investigations of watering from the eyes.</div><div class="table-scroll"><table data-label="TABLE 22.1" class="download">


<thead>
<tr>
<th class="left"><p class=""><span class="italic">Types of test</span></p></th>
<th class="left"><p class=""><span class="italic">Procedure</span></p></th>
</tr>
</thead>
<tbody>
<tr>
<td class="left"><p class=""><span class="italic">Saccharine,</span> or <span class="italic">quinine test (</span>alternately <span class="italic">chloramphenicol)</span></p></td>
<td class="left"><p class="">Sweet or bitter taste after instillation of solution in conjunctival sac. One eye is to be tested at a time.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Patency test (syringing)</span></p></td>
<td class="left"><p class="">Irrigation of lacrimal passage is done with distilled water by lacrimal cannula. Presence of water in the nasopharynx indicates a patent nasolacrimal passage.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Dye disappearance test</span></p></td>
<td class="left"><p class="">Fluorescein dye disappearance from the cul-de-sac (normal 2 minutes). A prolonged retention of dye indicates inadequate lacrimal drainage.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Jones I (primary) test</span></p></td>
<td class="left"><p class="">Appearance of fluorescein in the nose (5 minutes), after its conjunctival instillation. If no dye is recovered the test is called negative.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Jones II (secondary) test</span></p></td>
<td class="left"><p class="">Appearance of fluorescein in the nose after its lacrimal sac irrigation and indicates partial obstruction of nasolacrimal duct (NLD). If no dye is recovered the test is called negative, and probably due to canalicular block.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Probing test (<a href="#ch22fig11" class="ulink-inter">Figs. 22.11A and B</a>)</span></p></td>
<td class="left"><p class="">After insertion of a probe or cannula, an attempt is made to touch the medial wall of the lacrimal sac and the lacrimal bone. The interpretation may be a hard stop or a soft stop.</p>
<p class=""><ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Hard stop:</span> A firm to hard feeling caused by the probe–touching the medial wall of the sac against the lacrimal bone. It indicates that the lacrimal passage is patent up to the lacrimal sac and also indicates that the obstruction is below, i.e. at the NLD.</p></li>
<li><p class=""><span class="italic">Soft stop:</span> A spongy (soft) feeling as the probe presses the common canaliculus (CC) against the medial wall of the sac. It indicates either stenosis or obstruction of the canalicular system. However, an iatrogenic kinking of canalicular system during probing may also result in soft stop.</p></li>
</ul></p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Intubation dacryocystography (DCG)</span></p></td>
<td class="left"><p class="">X-rays (anteroposterior and lateral view) after injection of radio-opaque dye into the lacrimal sac. It demonstrates the location of obstruction, fistula, diverticula and tumors.</p></td>
</tr>
<tr>
<td class="left"><p class=""><span class="italic">Dacryoscintigraphy</span></p></td>
<td class="left"><p class="">Gamma camera tracing of technetium (99 mmTC) after instillation into cul-de-sac and its progress through the drainage system.</p></td>
</tr>
</tbody>
</table></div><div class="additional-markup"></div></div>
<div class="figure" id="ch22fig11" data-label="Figs. 22.11A and B"><div class="title"><span class="item-label">Figs. 22.11A and B</span> Probing test. <bold>A.</bold> Hard stop; <bold>B.</bold> Soft stop.</div><img alt="Figs. 22.11A and B" src="/MediumImage/413-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">To detect the position of anterior end of the middle turbinate when dacryocystorhinostomy (DCR) is contemplated.</p></li>
<li><p class="">To know the condition of the nasal mucosa <span class="italic">(atrophic rhinitis</span> may be a contraindication for DCR).</p></li>
<li><p class="">If the patient is interested for <bold>endoscopic</bold> DCR operation: In endoscopic DCR, the whole surgery is performed through the nostril, without any skin incision.<a name="page414"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">414</span></span></p></li>
</ul>
<div class="sidebar">
<p class=""><span class="italic">Patency (syringing) test (<a href="#ch22fig12" class="ulink-inter">Figs. 22.12A and B</a>):</span> A drop of topical lignocaine or proparacaine is instilled into the conjunctival sac. The lower punctum is dilated with a punctum dilator. A lacrimal cannula, on a 5 mL distilled water-filled syringe is inserted into the lower canaliculus. The piston is then pushed to irrigate the lacrimal passage. The result may be:</p>
<p class=""><ul style="list-style-type: bullet">
<li><p class="">Water is going freely into the nasopharynx— lacrimal passage is patent.</p></li>
<li><p class="">Water is regurgitating through the upper, and partly through the lower puncta:
<ul style="list-style-type: dash">
<li><p class=""><span class="italic">Fast regurgitation:</span> The fluid is clear and the regurgitation is rapid. It is due to common canalicular (CC) block.</p></li>
<li><p class=""><span class="italic">Slow regurgitation:</span> The fluid is turbid (as mixed with mucopus), and the regurgitation speed is slow. It is due to NLD block.</p></li>
</ul></p></li>
<li><p class="">Sometimes, fluid is going partially into the throat (and partly coming out through the puncta). It is due to partial NLD block.</p></li>
</ul></p>
</div>
</div>
<div class="section" id="ch22lev3sec9"><h3 class="title">Investigations for Surgery</h3>
<ul style="list-style-type: bullet">
<li><p class="">Blood for Hb%, total leukocyte count (TLC), differential leukocyte count (DLC) and erythrocyte sedimentation rate (ESR) is done.</p></li>
<li><p class="">Bleeding time and clotting time.</p></li>
<li><p class="">Blood sugar and blood pressure.</p></li>
<li><p class="">Serology for HIV, Hepatitis B and C.</p></li>
<li><p class="">General anesthesia fitness, if necessary.</p></li>
</ul>
</div>
</div>
</div><div class="section" id="ch22lev1sec5"><h1 class="title">DISEASES OF THE LACRIMAL PASSAGE</h1>
<div class="section" id="ch22lev2sec14"><h2 class="title">Canaliculitis</h2>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Acute canaliculitis</span> is usually due to herpes simplex infection and self-limiting.</p></li>
<li><p class=""><span class="italic">Chronic canaliculitis</span> is most commonly caused by <span class="italic">Actinomyces israelii</span> (streptothrix)
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Chronic infection causes:</span> Discharge, a pouting punctum and concretions within the canaliculi.</p></li>
<li><p class="">It also causes stone formation (dacryolith) in the lacrimal sac.</p></li>
<li><p class="">A gritty foreign body sensation during probing establishes the diagnosis.</p></li>
<li><p class=""><span class="italic">Treatment</span> of dacryolith is by a linear incision into the conjunctival side of the canaliculus (canaliculotomy).</p></li>
</ul></p></li>
</ul>
<p class="noindent"><span class="italic">Occlusion of the puncta and canaliculus:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Causes:</span>
<ul style="list-style-type: square">
<li><p class="">Congenital closure or maldevelopment.</p></li>
<li><p class="">Chronic blepharitis, ocular cicatricial pemphigoid, SJS.</p></li>
<li><p class="">Foreign body, e.g., eyelash <bold>(<a href="#ch22fig13" class="ulink-inter">Figs. 22.13A and B</a>)</bold> (most common) and concretion due to actinomycosis.</p></li>
<li><p class=""><span class="italic">Scarring:</span> It is due to burns, cosmetics, trauma or infections (trachoma and herpes simplex).</p>
<p class=""><div class="figure" id="ch22fig12" data-label="Figs. 22.12A and B"><div class="title"><span class="item-label">Figs. 22.12A and B</span> <bold>A.</bold> Patency (syringing) test; <bold>B.</bold> Syringing of the lacrimal passage.</div><img alt="Figs. 22.12A and B" src="/MediumImage/414-1.jpg"><div class="caption"><p class=""><bold>CC—</bold>Common canalicular; <bold>NLD—</bold>Nasolacrimal duct</p></div><div class="additional-markup"></div></div></p>
<p class=""><a name="page415"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">415</span></span></p>
<p class=""><div class="figure" id="ch22fig13" data-label="Figs. 22.13A and B"><div class="title"><span class="item-label">Figs. 22.13A and B</span> Eyelash. <bold>A.</bold> In upper punctum; <bold>B.</bold> In lower punctum (arrows).</div><img alt="Figs. 22.13A and B" src="/MediumImage/415-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Medications:</span> Topical, such as, timolol, latanoprost, tobramycin, etc., and systemic medications, such as 5-FU, docetaxel and paclitaxel.</p></li>
</ul></p></li>
<li><p class="">Slit-lamp examination is essential to establish the diagnosis.</p></li>
<li><p class=""><span class="italic">Treatment</span> is by removal of foreign body, or by dilating the canaliculus, and slitting it with a canaliculus knife. In case of CC block, conjunctivo-dacryocystorhinostomy (C-DCR) with a bypass tube is helpful.</p></li>
</ul>
</div>
<div class="section" id="ch22lev2sec15"><h2 class="title">Dacryocystitis</h2>
<p class="noindent">Dacryocystitis is an acute <bold>(<a href="#ch22fig14" class="ulink-inter">Fig. 22.14</a>)</bold> or chronic inflammation of the lacrimal sac. It is the sequel to obstruction of the NLD, or the sac itself, followed by bacterial infection.</p>
<div class="figure" id="ch22fig14" data-label="Fig. 22.14"><div class="title"><span class="item-label">Fig. 22.14</span> Acute dacryocystitis.</div><img alt="Fig. 22.14" src="/MediumImage/415-2.jpg"><div class="additional-markup"></div></div>
<div class="section" id="ch22lev3sec10"><h3 class="title">Etiology</h3>
<ul style="list-style-type: bullet">
<li><p class="">It is commonly seen among newborn infants (congenital type) and middle-aged women (7 times more common than men).</p></li>
<li><p class="">Left side is more commonly affected (left:right = 9:1).</p></li>
<li><p class="">More common in lower socioeconomic status.</p></li>
<li><p class=""><span class="italic">Causes</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Lacrimal passage proper:</span> NLD block due to narrowness or chronic inflammation of the sac.</p></li>
<li><p class=""><span class="italic">Nasal factors:</span> DNS, hypertrophied inferior turbinate, nasal polyps, etc.</p></li>
</ul></p></li>
<li><p class="">Following a primary conjunctivitis.</p></li>
<li><p class="">Infection spreading from the nasopharynx.</p></li>
<li><p class=""><span class="italic">Organisms responsible:</span> <span class="italic">Pneumococcus</span> (most common), <span class="italic">Streptococcus</span>, <span class="italic">Staphylococcus</span>, <span class="italic">Mycobacterium</span>, <span class="italic">Chlamydia</span>, etc.</p></li>
</ul>
</div>
<div class="section" id="ch22lev3sec11"><h3 class="title">Types</h3>
<ul style="list-style-type: bullet">
<li><p class="">Acute dacryocystitis</p></li>
<li><p class="">Chronic dacryocystitis
<ul style="list-style-type: square">
<li><p class="">Congenital type</p></li>
<li><p class="">Adult type.</p></li>
</ul></p></li>
</ul>
<div class="section" id="ch22lev4sec1"><h4 class="title">Acute dacryocystitis (<a href="#ch22fig15" class="ulink-inter">Fig. 22.15</a>)</h4>
<ul style="list-style-type: bullet">
<li><p class="">It is a suppurative inflammation of the lacrimal sac with an associated cellulitis of the overlying tissues.<a name="page416"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">416</span></span></p></li>
</ul>
<div class="figure" id="ch22fig15" data-label="Fig. 22.15"><div class="title"><span class="item-label">Fig. 22.15</span> Resolving acute dacryocystitis—right side.</div><img alt="Fig. 22.15" src="/MediumImage/416-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">The onset is acute, and there is a painful swelling below the inner canthus, often combined with widespread cellulitis.</p></li>
<li><p class="">The swelling is exquisitely tender with enlargement of the submandibular lymph node.</p></li>
<li><p class="">Constitutional symptoms like fever, malaise, etc., are present.</p></li>
<li><p class="">An abscess may often form, with perforation of the skin just below the medial palpebral ligament leading to formation of <span class="italic">lacrimal fistula (<a href="#ch22fig16" class="ulink-inter">Fig. 22.16</a>)</span>.</p></li>
</ul>
<p class="noindent"><span class="italic">Treatment</span></p>
<ul style="list-style-type: bullet">
<li><p class="">Local hot compresses 3–4 times daily</p></li>
<li><p class="">Broad-spectrum systemic antibiotics</p></li>
<li><p class="">Topical antibiotics 4–6 times daily</p></li>
<li><p class="">Systemic analgesics with antacids</p></li>
<li><p class="">In case of <span class="italic">lacrimal abscess</span> <bold>(<a href="#ch22fig17" class="ulink-inter">Fig. 22.17</a>)</bold> it is best done by incision and drainage technique under LA.
<ul style="list-style-type: square">
<li><p class="">In case of <span class="italic">lacrimal fistula</span> (whether formed naturally or artificially by drainage). It usually closes when the patency has been restored by DCR operation. Otherwise, the tract is excised along with dacryocystectomy (DCT) operation.</p></li>
<li><p class="">When everything is resolved a DCR or DCT operation has to be done as an elective procedure.</p></li>
</ul></p></li>
</ul>
<div class="figure" id="ch22fig16" data-label="Fig. 22.16"><div class="title"><span class="item-label">Fig. 22.16</span> Lacrimal fistula (arrow).</div><img alt="Fig. 22.16" src="/MediumImage/416-2.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch22fig17" data-label="Fig. 22.17"><div class="title"><span class="item-label">Fig. 22.17</span> Lacrimal abscess.</div><img alt="Fig. 22.17" src="/MediumImage/416-3.jpg"><div class="additional-markup"></div></div>
<p class="noindent"><span class="italic">Chronic Dacryocystitis (<a href="#ch22fig18" class="ulink-inter">Figs. 22.18</a> and <a href="#ch22fig19" class="ulink-inter">22.19</a>):</span></p>
<ul style="list-style-type: bullet">
<li><p class="">This is seen most frequently in newborns, infants and middle-aged women.</p></li>
<li><p class="">The chief symptoms are watering and a chronic mucopurulent discharge at the inner-angle of the eye.</p></li>
<li><p class="">There is regurgitation of pus or mucopus through the puncta, on pressure over the sac area.</p></li>
</ul>
<p class="noindent"><span class="italic">Congenital Chronic Dacryocystitis (<a href="#ch22fig18" class="ulink-inter">Fig. 22.18</a>):</span></p>
<ul style="list-style-type: bullet">
<li><p class="">It occurs in infants because of failure of the NLD to open into the inferior meatus of the nose, which normally occurs about third week of life.<a name="page417"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">417</span></span></p></li>
</ul>
<div class="figure" id="ch22fig18" data-label="Fig. 22.18"><div class="title"><span class="item-label">Fig. 22.18</span> Congenital dacryocystitis (right eye).</div><img alt="Fig. 22.18" src="/MediumImage/417-1.jpg"><div class="additional-markup"></div></div>
<div class="figure" id="ch22fig19" data-label="Fig. 22.19"><div class="title"><span class="item-label">Fig. 22.19</span> Chronic dacryocystitis (left eye).</div><img alt="Fig. 22.19" src="/MediumImage/417-2.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">The initial symptom is constant watering of one eye and it is followed by the regurgitation of pus through the puncta.</p></li>
<li><p class="">Congenital acute dacryocystitis is exceptional.</p></li>
<li><p class=""><span class="italic">Differential diagnosis:</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Neonatal conjunctivitis (ophthalmia neonatorum:</span> Usually bilateral, stickiness of the eyelids, no regurgitation of pus and quick response with antibiotic drops.</p></li>
<li><p class=""><span class="italic">Congenital glaucoma (buphthalmos):</span> There are associated blepharospasm and photophobia; cloudy cornea and raised intraocular tension.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Management:</span>
<ul style="list-style-type: square">
<li><p class=""><span class="italic">Hydrostatic sac massage and antibiotic drops:</span> By giving downward strokes, with index or little finger (10 strokes in each time) four times daily.</p>
<p class="">This should be followed by broad-spectrum antibiotic drops four times a day. This treatment is to be continued until the age of 6 months (some surgeons prefer till the age of 12 months). With this conservative treatment, canalization occurs in about 95% of cases.</p></li>
<li><p class=""><span class="italic">Probing:</span> It is usually done 10–12 months of age, under general anesthesia. The success rate decreases significantly after the age of 4 years. If there is no improvement after 4 weeks, the probing should be repeated.</p></li>
<li><p class=""><span class="italic">Intubation:</span> It may be done with silicone tube. If two probing's fail to cure the obstruction, the tube should be kept <span class="italic">in situ</span> for 6 months.</p></li>
<li><p class=""><span class="italic">Dacryocystorhinostomy:</span> It is required only in exceptional circumstances, and wisely delayed until the child is 4 years of age.</p></li>
</ul></p></li>
</ul>
<p class="noindent"><span class="italic">Adult Chronic Dacryocystitis (<a href="#ch22fig19" class="ulink-inter">Fig. 22.19</a>):</span></p>
<ul style="list-style-type: bullet">
<li><p class="">It typically occurs in postmenopausal women and either occurs spontaneously, or follows a lacrimal sac infection.</p></li>
<li><p class="">There may be spontaneous atresia of NLD, or weakness of the orbicularis, and it is often associated with nasal pathology.</p></li>
<li><p class="">In long-standing cases, there is extraordinary dilatation and thinning of the lacrimal sac called <span class="italic">mucocele</span> or <span class="italic">hydrops</span> of the lacrimal sac <bold>(<a href="#ch22fig20" class="ulink-inter">Fig. 22.20</a>)</bold>.</p></li>
<li><p class=""><span class="italic">Complications:</span>
<ul style="list-style-type: square">
<li><p class="">Chronic conjunctivitis</p></li>
<li><p class="">Recurrent attacks of acute conjunctivitis<a name="page418"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">418</span></span></p>
<p class=""><div class="figure" id="ch22fig20" data-label="Fig. 22.20"><div class="title"><span class="item-label">Fig. 22.20</span> Bilateral mucocele of the lacrimal sac.</div><img alt="Fig. 22.20" src="/MediumImage/418-1.jpg"><div class="additional-markup"></div></div></p></li>
<li><p class=""><span class="italic">Acute-on-chronic</span> dacryocystitis</p></li>
<li><p class="">From acute dacryocystitis, there may be chance of:
<ul style="list-style-type: dash">
<li><p class="">Lacrimal abscess and consequently, pyogenic granuloma <bold>(<a href="#ch22fig21" class="ulink-inter">Fig. 22.21A</a>)</bold></p></li>
<li><p class="">Lacrimal fistula</p></li>
<li><p class="">Orbital and facial cellulitis</p></li>
<li><p class="">Cavernous sinus thrombosis</p></li>
<li><p class="">Lacrimal osteomyelitis, etc.</p></li>
</ul></p></li>
<li><p class=""><span class="italic">Hypopyon corneal ulcer:</span> Chronic dacryocystitis <bold>(<a href="#ch22fig21" class="ulink-inter">Fig. 22.21B</a>)</bold> is in fact a constant menace to the ophthalmologist or to the patient, as mild corneal abrasion due to any cause may be turned into a hypopyon corneal ulcer, which is mostly due to <span class="italic">Pneumococci.</span></p></li>
</ul></p></li>
</ul>
<p class="noindent"><span class="italic">Treatment:</span></p>
<ul style="list-style-type: bullet">
<li><p class=""><span class="italic">Symptomatic relief</span> is often obtained by broad-spectrum antibiotic eye drops (e.g., Moxifloxacin or Gatifloxacin).</p></li>
<li><p class=""><span class="italic">Dacryocystorhinostomy:</span> The surgical procedure of choice is DCR operation, in which a communication is established between the lacrimal sac and the middle meatus of the nose.</p></li>
<li><p class=""><span class="italic">Dacryocystectomy:</span> It means simple removal of the lacrimal sac. The main idea is to eliminate the reservoir of infection and regurgitation of pus into the conjunctival sac. But watering will continue throughout the life.
<ul style="list-style-type: square">
<li><p class="">In extreme old age.</p></li>
<li><p class="">When the sac is shrunken and fibrotic.</p></li>
<li><p class="">In presence of growth of the sac.</p></li>
<li><p class="">In obvious nasal pathology, like atrophic rhinitis.</p></li>
</ul></p></li>
</ul>
<p class="noindent">(For operative details <span class="italic">see</span> <a href="/9789356963825/chapter/ch25" class="ulink-exter">Chapter 25</a>).</p>
</div>
</div>
</div>
</div><div class="section" id="ch22lev1sec6"><h1 class="title">TUMORS OF THE LACRIMAL SAC (<a href="#ch22fig22" class="ulink-inter">FIG. 22.22</a>)</h1>
<ul style="list-style-type: bullet">
<li><p class="">Tumors of the lacrimal sac are extremely rare and represent a potentially life- threatening condition.</p></li>
</ul>
<div class="figure" id="ch22fig21" data-label="Figs. 22.21A and B"><div class="title"><span class="item-label">Figs. 22.21A and B</span> <bold>A.</bold> Lacrimal abscess with pyogenic granuloma at the puncta; <bold>B.</bold> Chronic dacryocystitis with corneal ulcer.</div><img alt="Figs. 22.21A and B" src="/MediumImage/418-2.jpg"><div class="additional-markup"></div></div>
<p class=""><a name="page419"></a><span class="pageBreak"></span><span class="pageNumbers"><span class="bottomPage">419</span></span></p>
<div class="figure" id="ch22fig22" data-label="Fig. 22.22"><div class="title"><span class="item-label">Fig. 22.22</span> Carcinoma of the lacrimal sac.</div><img alt="Fig. 22.22" src="/MediumImage/419-1.jpg"><div class="additional-markup"></div></div>
<ul style="list-style-type: bullet">
<li><p class="">Most neoplasms are squamous cell carcinomas, transitional cell carcinomas and adenocarcinomas.</p></li>
<li><p class="">The triad of malignancy are:
<ul style="list-style-type: square">
<li><p class="">A mass below the medial palpebral ligament <bold>(<a href="#ch22fig22" class="ulink-inter">Fig. 22.22</a>)</bold></p></li>
<li><p class="">A chronic dacryocystitis that irrigates freely and</p></li>
<li><p class="">Regurgitation of bloody mucopus.</p></li>
</ul></p></li>
<li><p class="">Dacryocystography shows a filling defect.</p></li>
<li><p class=""><span class="italic">Treatment</span> is by complete excision of the sac followed by irradiation.</p></li>
</ul>
</div></div></div>